Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.68
-0.98 (-12.79%)
At close: Apr 17, 2026, 4:00 PM EDT
6.70
+0.02 (0.30%)
After-hours: Apr 17, 2026, 7:55 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $41.33 million as of April 17, 2026. Its market cap has decreased by -10.81% in one year.
Market Cap
41.33M
Enterprise Value
-31.26M
1-Year Change
-10.81%
Ranking
Category
Stock Price
$6.68
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $41.33M, a decrease of -92.53%. That is a compound annual growth rate of -37.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 41.33M | -27.93% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Plus Therapeutics | 43.85M |
| Rallybio | 43.48M |
| Atara Biotherapeutics | 43.10M |
| Daré Bioscience | 42.95M |
| Lite Strategy | 42.91M |
| Lixte Biotechnology Holdings | 41.94M |
| Sensei Biotherapeutics | 40.87M |
| Actinium Pharmaceuticals | 40.53M |